A miRNA-101-3p/Bim axis as a determinant of serum deprivation-induced endothelial cell apoptosis

Cell Death and Disease

Volumn 8, Issue 5, 2017, Pages

  Kim, Ji Hee ^a   Lee, Dong Keon ^a   Kim, Joohwan ^a   Choi, Seunghwan ^a   Park, Wonjin ^a   Ha, Kwon Soo ^a   Kim, Tae Hoon ^a   Choe, Jongseon ^a   Won, Moo Ho ^a   Kwon, Young Guen ^b   Kim, Young Myeong ^a  

^a Kangwon National University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARGONAUTE PROTEIN; BIM PROTEIN; CASPASE; INFLAMMASOME; MICRORNA; MIRN101 MICRORNA, HUMAN; REACTIVE OXYGEN METABOLITE; RIBONUCLEASE III;

APOPTOSIS; BIOLOGICAL MODEL; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; ENZYME ACTIVATION; HUMAN; METABOLISM; MITOCHONDRION; SERUM-FREE MEDIUM; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIOXIDANTS; APOPTOSIS; ARGONAUTE PROTEINS; BCL-2-LIKE PROTEIN 11; CASPASES; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; DOWN-REGULATION; ENZYME ACTIVATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMASOMES; MICRORNAS; MITOCHONDRIA; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES; RIBONUCLEASE III; SIGNAL TRANSDUCTION;

EID: 85028978904     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/CDDIS.2017.219     Document Type: Article

References (47)

1. Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 2005; 1: 183–198.
2. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115: 1285–1295.
3. Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005; 2: 1463–1467.
4. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107–120.
5. de Vries EG, Gietema JA, de Jong S. Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications. Clin Cancer Res 2006; 12: 2390–2393.
6. McClintock DS, Santore MT, Lee VY, Brunelle J, Budinger GR, Zong WX et al. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 2002; 22: 94–104.
7. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13: 1899–1911.
8. Delbridge AR, Strasser A. The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ 2015; 22: 1071–1080.
9. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15: 49–63.
10. Wang S, Park S, Fei P, Sorenson CM. Bim is responsible for the inherent sensitivity of the developing retinal vasculature to hyperoxia. Dev Biol 2011; 349: 296–309.
11. Xi H, Zhang Y, Xu Y, Yang WY, Jiang X, Sha X et al. Caspase-1 inflammasome activation mediates homocysteine-induced Pyrop-apoptosis in endothelial cells. Circ Res 2016; 118: 1525–1539.
12. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221–225.
13. Xi H, Zhang Y, Xu Y, Yang WY, Jiang X, Sha X et al. Caspase-1 inflammasome activation mediates homocysteine-induced pyrop apoptosis in endothelial cells. Circ Res 2016; 118: 1525–1539.
14. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.
15. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009; 119: 2772–2786.
16. Quiat D, Olson EN. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest 2013; 123: 11–18.
17. Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F et al. Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res 2010; 70: 3140–3149.
18. Zhang CZ, Zhang JX, Zhang AL, Shi ZD, Han L, Jia ZF et al. MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 2010; 9: 229.
19. Li Y, Choi PS, Casey SC, Dill DL, Felsher DW. MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state. Cancer Cell 2014; 26: 262–272.
20. Kim JH, Lee KS, Lee DK, Kim J, Kwak SN, Ha KS et al. Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3. Antioxid Redox Signal 2014; 21: 2469–2482.
21. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11: 228–234.
22. Hawkins SM, Andreu-Vieyra CV, Kim TH, Jeong JW, Hodgson MC, Chen R et al. Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer. Mol Endocrinol 2012; 26: 1552–1566.
23. Hogg N, Browning J, Howard T, Winterford C, Fitzpatrick D, Gobé G. Apoptosis in vascular endothelial cells caused by serum deprivation, oxidative stress and transforming growth factor-β. Endothelium 1999; 7: 35–49.
24. Cotter TG. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009; 9: 501–507.
25. Sollberger G, Strittmatter GE, Grossi S, Garstkiewicz M, Auf dem Keller U, French LE et al. Caspase-1 activity is required for UVB-induced apoptosis of human keratinocytes. J Invest Dermatol 2015; 135: 1395–1404.
26. Lamkanfi M, Kanneganti TD, Van Damme P, Vanden Berghe T, Vanoverberghe I, Vandekerckhove J et al. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol Cell Proteomics 2008; 7: 2350–2363.
27. Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J Thorac Oncol 2011; 6: 671–678.
28. Asada S, Takahashi T, Isodono K, Adachi A, Imoto H, Ogata T et al. Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis. Am J Physiol Heart Circ Physiol 2008; 295: H2512–H2521.
29. Peterson QP, Goode DR, West DC, Botham RC, Hergenrother PJ. Preparation of the caspase-3/7 substrate Ac-DEVD-pNA by solution-phase peptide synthesis. Nat Protoc 2010; 5: 294–302.
30. Gibbings D, Mostowy S, Jay F, Schwab Y, Cossart P, Voinnet O. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol 2012; 14: 1314–1321.
31. Liu X, Tang H, Chen J, Song C, Yang L, Liu P et al. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer. Oncotarget 2015; 6: 20070–20083.
32. Liu P, Ye F, Xie X, Li X, Tang H, Li S et al. mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK. Oncotarget 2016; 7: 35188–35198.
33. Koenig MN, Naik E, Rohrbeck L, Herold MJ, Trounson E, Bouillet P et al. Pro apoptotic BIM is an essential initiator of physiological endothelial cell death independent of regulation by FOXO3. Cell Death Differ 2014; 21: 1687–1695.
34. Kong PJ, Kil MO, Lee H, Kim SS, Johnson GV, Chun W. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line. Neurol Res 2009; 31: 77–83.
35. Mojsa B, Mora S, Bossowski JP, Lassot I, Desagher S. Control of neuronal apoptosis by reciprocal regulation of NFATc3 and Trim17. Cell Death Differ 2015; 22: 274–286.
36. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008; 132: 875–886.
37. Pernaute B, Spruce T, Smith KM, Sánchez-Nieto JM, Manzanares M, Cobb B et al. MicroRNAs control the apoptotic threshold in primed pluripotent stem cells through regulation of BIM. Genes Dev 2014; 28: 1873–1878.
38. Bu Q, Fang Y, Cao Y, Chen Q, Liu Y. Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway. Mol Med Rep 2014; 10: 2203–2209.
39. Zhao X, Wang K, Hu F, Qian C, Guan H, Feng K et al. MicroRNA-101 protects cardiac fibroblasts from hypoxia-induced apoptosis via inhibition of the TGF-β signaling pathway. Int J Biochem Cell Biol 2015; 65: 155–164.
40. Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 2004; 95: 957–970.
41. Kim YM, Kim JH, Kwon HM, Lee DH, Won MH, Kwon YG et al. Korean Red Ginseng protects endothelial cells from serum-deprived apoptosis by regulating Bcl-2 family protein dynamics and caspase S-nitrosylation. J Ginseng Res 2013; 37: 413–424.
42. Min JK, Kim JH, Cho YL, Maeng YS, Lee SJ, Pyun BJ et al. 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochem Biophys Res Commun 2006; 349: 987–994.
43. Liang M, Russell G, Hulley PA. Bim, Bak, and Bax regulate osteoblast survival. J Bone Miner Res 2008; 23: 610–620.
44. Naik E, O’Reilly LA, Asselin-Labat ML, Merino D, Lin A, Cook M et al. Destruction of tumor vasculature and abated tumor growth upon VEGF blockade is driven by proapoptotic protein Bim in endothelial cells. J Exp Med 2011; 208: 1351–1358.
45. Kaushal V, Dye R, Pakavathkumar P, Foveau B, Flores J, Hyman B et al. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation. Cell Death Differ 2015; 22: 1676–1686.
46. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell 2002; 10: 417–426.
47. Hagenbuchner J, Ausserlechner MJ. Mitochondria and FOXO3: breath or die. Front Physiol 2013; 4: 147.